Contact
Please use this form to send email to PR contact of this press release:
AC Immune’s ACI-35.030 (now “JNJ-2056”) Granted FDA Fast Track Designation for Alzheimer’s Disease
TO:
Please use this form to send email to PR contact of this press release:
AC Immune’s ACI-35.030 (now “JNJ-2056”) Granted FDA Fast Track Designation for Alzheimer’s Disease
TO: